Aerium Therapeutics
Signal active
Organization
Contact Information
Overview
Aerium Therapeutics is discovering and developing novel monoclonal antibodies (mAbs) and antiviral treatments against SARS-CoV-2 variants.
About
Industries
Health Care, Pharmaceutical, Medical, Biopharma, Therapeutics
Founded
2021
Employees
1-10
Headquarters locations
Boston, Massachusetts, United States, North America
Social
Profile Resume
Aerium Therapeutics headquartered in United States, North America, operates in the Health Care, Pharmaceutical, Medical, Biopharma, Therapeutics sector. With a team of 1-10 employees, Aerium Therapeutics is actively contributing to advancements in Health Care. Their latest funding round, Series A - Aerium Therapeutics, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
2
Lead Investors
0
Total Funding Amount
$0
Details
1
Aerium Therapeutics has raised a total of $0 in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2022 | Early Stage Venture |
Investors
Aerium Therapeutics is funded by 8 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Omega Funds | - | FUNDING ROUND - Omega Funds | undefined |
| Stephen Knight | - | FUNDING ROUND - Stephen Knight | undefined |
| Aerium Therapeutics | - | FUNDING ROUND - Aerium Therapeutics | undefined |
| F-Prime Capital | - | FUNDING ROUND - F-Prime Capital | undefined |